Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation

Eur J Clin Microbiol Infect Dis. 2021 Mar 10. doi: 10.1007/s10096-021-04186-6. Online ahead of print.

ABSTRACT

Nocardiosis is a life-threatening opportunistic infection in immunocompromised patients. Herein, we present successful adjunctive use of liposomal nebulized amikacin and tedizolid in a recipient of allogeneic hematopoietic stem cell transplantation infected with Nocardia nova complex who presented multiple complications to conventional therapeutic options.

PMID:33694036 | DOI:10.1007/s10096-021-04186-6